Stefan Kappe of Seattle BioMed in the U.S., one of the original Grand Challenges in Global Health grantees, has used genetic engineering to develop an attenuated live malaria vaccine candidate for testing in clinical trials. Learn more about this project and the impact that Grand Challenges in Global Health funding had on the research timeline.
